The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Gliadel 7.7 mg Implant

MGI Pharma GmbHPA22740/001/001

Main Information

Trade NameGliadel 7.7 mg Implant
Active SubstancesCarmustine
Dosage FormImplant
Licence HolderMGI Pharma GmbH
Licence NumberPA22740/001/001

Group Information

ATC CodeL01AD Nitrosoureas
L01AD01 carmustine


License statusAuthorised
Licence Issued07/07/1999
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back